About DC Chemicals
Established in 2013 , DC Chemicals (www.dcchemicals.com) is a world-leading supplier of drug active molecules.
Our Products
DC Chemicals is committed to providing global drug research and development as well as medical research clients with a wide range of innovative and comprehensive high-quality small molecule active compounds. We offer over 10,000 specific inhibitors, agonists, and cationic liposomes that act on gene delivery, gene editing, RNA vaccines, epigenetics, PI3K/Akt/mTOR, apoptosis, MAPK, Wnt, and other 20 signaling pathways with more than 1,000 target proteins, covering popular disease research areas such as cancer, neuroscience, and immunology. DC Chemicals has many globally exclusive compounds and a professional team tracking new pharmaceutical and life science research progress, which can provide you with the latest research small molecule compounds to meet your research needs.
Our Features
As one of the earliest companies in the world to develop and research cationic liposomes, DC Chemicals provides a large number of liposomes for global RNA and gene editing companies for LNP research and screening. DC Chemicals currently has one of the largest cationic/ionizable liposome libraries in the world. Cationic liposomes are the core components of LNP and are currently the most core technology for gene delivery. Our liposomes follow the latest frontier structures and can provide clients with liposome samples from mg to g levels to facilitate clients' rapid access to liposomes for LNP research.
Our Advantages
Our small molecule compounds are at least 10% cheaper compared to other large reagent companies (Selleck Chemicals, Medchemexpress, etc.), and under our strict quality control, our quality is equal to or better than similar reagent companies. Especially for animal experiments that require a large amount of small molecule compounds for in vivo experiments, our price advantage is more obvious, which can save clients a lot of research costs. We have a warehouse department in New York that can provide overnight shipping to clients.
Our Customers
DC Chemicals has established in-depth cooperation with more than 500 global drug research centers and pharmaceutical companies, including close cooperation with pharmaceutical companies and reagent companies in Europe, Japan, and the United States. Pharmaceutical companies include Johnson & Johnson, Pfizer, Novartis, Merck EMD, Eli Lilly, Sanofi-Aventis, etc. DC Chemicals has also established cooperation with more than 100 universities and research institutions worldwide, including Harvard University, Yale University, NIH-NCI, Johns Hopkins University, Oxford University, Newcastle University, UNC, University of California, San Francisco (UCSF), and many other universities and research institutions. Our drug active small molecule compounds have received good feedback from clients.
Our Quality
We conduct strict testing on each batch of compounds, including HNMR, HPLC, and MS testing, to ensure that the purity of each batch of compounds is >98%. High-purity compounds can maximize the accuracy and reliability of experiments.
Our Team
We have more than 50 engineers in the field of organic chemistry and life sciences in our Shanghai, China office to provide synthesis services and technical support. All engineers have a master's degree or above and at least 5 years of work experience in related fields.
Our Services
Our strong chemistry team in China can provide global scientific research and pharmaceutical companies with custom organic synthesis services from mg to kg levels. In addition, we also provide outsourcing and testing services from Chinese manufacturers for global clients.
